Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inflammation and anaemia in a broad spectrum of patients with heart failure.
Kleijn L, Belonje AM, Voors AA, De Boer RA, Jaarsma T, Ghosh S, Kim J, Hillege HL, Van Gilst WH, van Veldhuisen DJ, van der Meer P. Kleijn L, et al. Among authors: belonje am. Heart. 2012 Aug;98(16):1237-41. doi: 10.1136/heartjnl-2012-301954. Epub 2012 Jun 22. Heart. 2012. PMID: 22730482
Vitamin D status and outcomes in heart failure patients.
Liu LC, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, Silljé HH, van Gilst WH, Jaarsma T, de Boer RA. Liu LC, et al. Among authors: belonje am. Eur J Heart Fail. 2011 Jun;13(6):619-25. doi: 10.1093/eurjhf/hfr032. Epub 2011 May 4. Eur J Heart Fail. 2011. PMID: 21543375 Free article. Clinical Trial.
Erythropoietin in chronic heart failure.
Belonje AM, Voors AA, van Gilst WH, van Veldhuisen DJ. Belonje AM, et al. Congest Heart Fail. 2007 Sep-Oct;13(5):289-92. doi: 10.1111/j.1527-5299.2007.06662.x. Congest Heart Fail. 2007. PMID: 17917496 Free article. Review.
Endogenous erythropoietin and outcome in heart failure.
Belonje AM, Voors AA, van der Meer P, van Gilst WH, Jaarsma T, van Veldhuisen DJ. Belonje AM, et al. Circulation. 2010 Jan 19;121(2):245-51. doi: 10.1161/CIRCULATIONAHA.108.844662. Epub 2010 Jan 4. Circulation. 2010. PMID: 20048213
Long term effects of epoetin alfa in patients with ST- elevation myocardial infarction.
Fokkema ML, Kleijn L, van der Meer P, Belonje AM, Achterhof SK, Hillege HL, van 't Hof A, Jukema JW, Peels HO, Henriques JP, ten Berg JM, Vos J, van Gilst WH, van Veldhuisen DJ, Voors AA. Fokkema ML, et al. Among authors: belonje am. Cardiovasc Drugs Ther. 2013 Oct;27(5):433-9. doi: 10.1007/s10557-013-6470-0. Cardiovasc Drugs Ther. 2013. PMID: 23784615 Clinical Trial.
Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: a meta-analysis of individual patient data.
Fokkema ML, van der Meer P, Rao SV, Belonje AM, Ferrario M, Hillege HL, Katz SD, Lipšic E, Ludman AJ, Ott I, Prunier F, Choi DJ, Toba K, van Veldhuisen DJ, Voors AA. Fokkema ML, et al. Among authors: belonje am. Am Heart J. 2014 Sep;168(3):354-362.e2. doi: 10.1016/j.ahj.2014.04.020. Epub 2014 Jun 9. Am Heart J. 2014. PMID: 25173548 Review.
Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
Westenbrink BD, Oeseburg H, Kleijn L, van der Harst P, Belonje AM, Voors AA, Schoemaker RG, de Boer RA, van Veldhuisen DJ, van Gilst WH. Westenbrink BD, et al. Among authors: belonje am. Cardiovasc Drugs Ther. 2008 Aug;22(4):265-74. doi: 10.1007/s10557-008-6094-y. Epub 2008 Mar 11. Cardiovasc Drugs Ther. 2008. PMID: 18327705
A single dose of erythropoietin in ST-elevation myocardial infarction.
Voors AA, Belonje AM, Zijlstra F, Hillege HL, Anker SD, Slart RH, Tio RA, van 't Hof A, Jukema JW, Peels HO, Henriques JP, Ten Berg JM, Vos J, van Gilst WH, van Veldhuisen DJ; HEBE III Investigators. Voors AA, et al. Among authors: belonje am. Eur Heart J. 2010 Nov;31(21):2593-600. doi: 10.1093/eurheartj/ehq304. Epub 2010 Aug 29. Eur Heart J. 2010. PMID: 20802250 Clinical Trial.
14 results